BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26621371)

  • 1. A Novel Assay to Identify the Trafficking Proteins that Bind to Specific Vesicle Populations.
    Bentley M; Banker G
    Curr Protoc Cell Biol; 2015 Dec; 69():13.8.1-13.8.12. PubMed ID: 26621371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel split kinesin assay identifies motor proteins that interact with distinct vesicle populations.
    Jenkins B; Decker H; Bentley M; Luisi J; Banker G
    J Cell Biol; 2012 Aug; 198(4):749-61. PubMed ID: 22908316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel assay reveals preferential binding between Rabs, kinesins, and specific endosomal subpopulations.
    Bentley M; Decker H; Luisi J; Banker G
    J Cell Biol; 2015 Feb; 208(3):273-81. PubMed ID: 25624392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualizing Vesicle-Bound Kinesins in Cultured Hippocampal Neurons.
    Montgomery A; Garbouchian A; Bentley M
    Methods Mol Biol; 2022; 2431():239-247. PubMed ID: 35412280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel strategy to visualize vesicle-bound kinesins reveals the diversity of kinesin-mediated transport.
    Yang R; Bostick Z; Garbouchian A; Luisi J; Banker G; Bentley M
    Traffic; 2019 Nov; 20(11):851-866. PubMed ID: 31461551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the FKBP.rapamycin.FRB ternary complex.
    Banaszynski LA; Liu CW; Wandless TJ
    J Am Chem Soc; 2005 Apr; 127(13):4715-21. PubMed ID: 15796538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation tool for FKBP12-dependent and -independent mTOR inhibitors using a combination of FKBP-mTOR fusion protein, DSC and NMR.
    Sekiguchi M; Kobashigawa Y; Kawasaki M; Yokochi M; Kiso T; Suzumura K; Mori K; Teramura T; Inagaki F
    Protein Eng Des Sel; 2011 Nov; 24(11):811-7. PubMed ID: 21900305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FKBP-rapamycin binding domain of human TOR undergoes strong conformational changes in the presence of membrane mimetics with and without the regulator phosphatidic acid.
    Rodriguez Camargo DC; Link NM; Dames SA
    Biochemistry; 2012 Jun; 51(24):4909-21. PubMed ID: 22620485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rapamycin-binding domain of the protein kinase mammalian target of rapamycin is a destabilizing domain.
    Edwards SR; Wandless TJ
    J Biol Chem; 2007 May; 282(18):13395-401. PubMed ID: 17350953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP-FRB Interaction and Autophagy.
    Parada CA; de Oliveira IP; Gewehr MCF; Machado-Neto JA; Lima K; Eichler RAS; Lopes LR; Bechara LRG; Ferreira JCB; Festuccia WT; Censoni L; Tersariol ILS; Ferro ES
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccharomyces cerevisiae FKBP12 binds Arabidopsis thaliana TOR and its expression in plants leads to rapamycin susceptibility.
    Sormani R; Yao L; Menand B; Ennar N; Lecampion C; Meyer C; Robaglia C
    BMC Plant Biol; 2007 Jun; 7():26. PubMed ID: 17543119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological constraints limit the use of rapamycin-inducible FKBP12-Inp54p for depleting PIP2 in dorsal root ganglia neurons.
    Coutinho-Budd JC; Snider SB; Fitzpatrick BJ; Rittiner JE; Zylka MJ
    J Negat Results Biomed; 2013 Sep; 12():13. PubMed ID: 24010830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN21 and Hook3 relieve KIF1C autoinhibition and activate intracellular transport.
    Siddiqui N; Zwetsloot AJ; Bachmann A; Roth D; Hussain H; Brandt J; Kaverina I; Straube A
    Nat Commun; 2019 Jun; 10(1):2693. PubMed ID: 31217419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.
    Veverka V; Crabbe T; Bird I; Lennie G; Muskett FW; Taylor RJ; Carr MD
    Oncogene; 2008 Jan; 27(5):585-95. PubMed ID: 17684489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concerted action of kinesins KIF5B and KIF13B promotes efficient secretory vesicle transport to microtubule plus ends.
    Serra-Marques A; Martin M; Katrukha EA; Grigoriev I; Peeters CA; Liu Q; Hooikaas PJ; Yao Y; Solianova V; Smal I; Pedersen LB; Meijering E; Kapitein LC; Akhmanova A
    Elife; 2020 Nov; 9():. PubMed ID: 33174839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro motility of liver connexin vesicles along microtubules utilizes kinesin motors.
    Fort AG; Murray JW; Dandachi N; Davidson MW; Dermietzel R; Wolkoff AW; Spray DC
    J Biol Chem; 2011 Jul; 286(26):22875-85. PubMed ID: 21536677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glycerol-water mixtures in the stability of FKBP12-rapalog-FRB complexes.
    Lopez JJD; Gaza JT; Nellas RB
    J Mol Graph Model; 2023 Nov; 124():108556. PubMed ID: 37423019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditionally controlling nuclear trafficking in yeast by chemical-induced protein dimerization.
    Xu T; Johnson CA; Gestwicki JE; Kumar A
    Nat Protoc; 2010 Nov; 5(11):1831-43. PubMed ID: 21030958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of Extracellular Vesicles for Small Molecule-Regulated Cargo Loading and Cytoplasmic Delivery of Bioactive Proteins.
    Somiya M; Kuroda S
    Mol Pharm; 2022 Jul; 19(7):2495-2505. PubMed ID: 35594496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FKBP12: A partner of Snx10 required for vesicular trafficking in osteoclasts.
    Battaglino RA; Jha P; Sultana F; Liu W; Morse LR
    J Cell Biochem; 2019 Aug; 120(8):13321-13329. PubMed ID: 30887568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.